US Patent 11858983 C-terminal anti-sclerostin antibody variants

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118589830

Patent Inventor Names

Szilan Fodor0

Mark Daris0

Greg Flynn0

Zhe Huang0

Jennitte LeAnn Stevens0

Date of Patent

January 2, 2024

Patent Application Number

179345850

Date Filed

September 23, 2022

Patent Citations

‌

US Patent 7381409 Antibodies specific for sclerostin and methods of screening and use therefor

‌

US Patent 7572899 Compositions and methods for increasing bone mineralization

‌

US Patent 7578999 Antibodies specific for sclerostin

‌

US Patent 7592429 Sclerostin-binding antibody

‌

US Patent 7642238 Molecular determinants of myeloma bone disease and uses thereof

‌

US Patent 7758858 Antibodies associated with alterations in bone density

‌

US Patent 7868134 Immunogenic peptides derived from sclerostin

‌

US Patent 7872106 Sclerostin-binding antibodies

...

Patent Primary Examiner

‌

Christine J. Saoud

Patent abstract

The invention generally relates to anti-sclerostin antibodies having C-terminal modifications, and compositions comprising such antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11858983 C-terminal anti-sclerostin antibody variants

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11858983 C-terminal anti-sclerostin antibody variants